Ligand Pharmaceuticals Inc. (LGND)

NASDAQ

$303.45

$-5.01

(-1.63%)

Previous Close: ⁦$307.82⁩

Market Closed

Ligand Pharmaceuticals Inc. (LGND) Live Price Chart

Last updated: ⁦2026-10-24 06:51:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Ligand Pharmaceuticals Inc. (LGND) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $303.45, with a market capitalization of $6.14B and a P/E ratio of 31.12. Over the past 52 weeks, its price has ranged from $175.89 to $326.63. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$6.14B
Open	$307.82
Day's High	$326.63
Day's Low	$6.60
Previous Close	$307.82
Volume	307.02K
Average Volume	244.64K
P/E Ratio	31.12
52-Week High	$326.63
52-Week Low	$175.89
Dividend Yield	--
Earnings Date	--

Ligand Pharmaceuticals Inc. (LGND) Latest Closing Stock Price

Ligand Pharmaceuticals Inc. (LGND) last closed at $307.82 as of 2026-10-23 23:31:00, unchanged from the previous close of $307.82.

During the latest regular trading session, LGND traded between $6.60 and $326.63, with a volume of 307.02K shares. The closing price was near the upper end and near the upper end of its 52-week range.

Ligand Pharmaceuticals Inc. (LGND) 7-Day Stock Price Change

Over the past seven days, Ligand Pharmaceuticals Inc. (LGND) moved from $298.50 to $303.45, representing a gain of 1.66% ($4.95).

The stock traded between $292.56 and $317.64 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 241.40 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

LGND 52-Week Price Position

Position in Range: 84.6%

52W Low$175.89

52W High$326.63

LGND is currently trading at $303.45, placing it 84.6% of the way from its 52-week low of $175.89 to its 52-week high of $326.63. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Ligand Pharmaceuticals Inc. (LGND)?

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Ligand Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	47
Exchange	NASDAQ
Company Website	https://www.ligand.com

How to Buy Ligand Pharmaceuticals Inc. (LGND) Stock on MEXC

Eligible investors can buy real shares of Ligand Pharmaceuticals Inc. (LGND) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LGND and Place Your Order

Open the RealStocks trading page and search for LGND. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ligand Pharmaceuticals Inc. (LGND) stock price today?

Ligand Pharmaceuticals Inc. (LGND) is currently trading at $ 303.45, down 1.42% ($4.37) from the previous close of $ 307.82. Intraday prices update in real time during regular trading hours.

2.Is LGND stock going up or down today?

As of 2026-10-23 23:31:00, LGND is trading at $ 303.45, down 1.42% ($4.37) from its previous close of $ 307.82. The stock has traded between $ 6.60 and $ 326.63 during today’s regular session. Past price movements do not guarantee future results.

3.What is LGND pre-market price?

As of 2026-10-23 23:31:00, LGND is trading at $ 306.97 in pre-market trading, down 0.28% ($0.86) from the previous close of $ 307.82. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LGND after-hours price?

As of 2026-10-23 23:31:00, LGND is trading at $ 303.49 in after-hours trading, down 1.41% ($4.33) from the regular-session close of $ 307.82. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LGND stock trading now?

LGND trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LGND sit relative to its 52-week high and low?

Over the past 52 weeks, LGND has traded between a low of $ 175.89 and a high of $ 326.63. At $ 303.45, the stock is positioned 84.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ligand Pharmaceuticals Inc. in?

Ligand Pharmaceuticals Inc. (LGND) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ligand Pharmaceuticals Inc.'s market capitalization and where is it listed?

Ligand Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalization of $ 6.14B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LGND valued in terms of P/E ratio and EPS?

LGND trades at a P/E ratio of 31.12, based on trailing-twelve-month EPS of $ 9.89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ligand Pharmaceuticals Inc. pay a dividend?

Ligand Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.